Deutsche Bank Research Cuts Ottobock PT, Keeps Buy Rating

MT Newswires · 23h ago
08:37 AM EST, 11/17/2026 (MT Newswires) -- Deutsche Bank Research on Tuesday reduced its price target for medical technology company Ottobock (OBCK.F) to 56 euros from 85 euros, with an unchanged buy rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)